Severe COVID-19 may trigger the reactivation of dormant viruses in the body, according to research conducted by Boston Children’s Hospital and over 20 other biomedical institutions across the U.S. and Canada. The study examined 1,154 hospitalized COVID-19 patients, analyzing more than 200,000 biological samples collected over a year. Researchers found that 11 types of dormant viruses, including several herpes viruses such as Epstein-Barr and cytomegalovirus, reactivated within the first 40 days following hospital admission. This reactivation was notably associated with long-term physical disabilities and long COVID symptoms, although the study did not establish a direct causative link. The findings suggest a potential mechanism for viral reactivation during severe illnesses, highlighting the need for further research to understand the implications for COVID-19 outcomes.
Why It Matters
Understanding the reactivation of dormant viruses during severe COVID-19 is crucial for developing better treatments and diagnostic tools. Historically, diseases such as long COVID have been challenging to study, and the interaction between SARS-CoV-2 and other viruses may complicate patient outcomes. The presence of reactivated viruses like Anelloviridae, traditionally considered harmless, raises questions about their role in long-term health issues. With millions of Americans experiencing long COVID and ongoing COVID-19-related health challenges, this research could have significant implications for public health and future medical interventions.
Want More Context? 🔎
